Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Pramipexole can cause side effects like dizziness, sleepiness, hallucinations, and low blood pressure, and it's important to educate patients and keep doses low.

A gene in Arabidopsis thaliana, AtPRPL1, affects root hair length but not cell wall composition.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Classic PDRN improves wound healing quality by enhancing cell migration.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Androgen receptors help prostate cancer cells grow and resist drugs.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

Targeting catecholaminergic signaling may help treat keloid scars.

The PML protein helps prevent skin cancer in mice.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

PP405 may help hair growth by activating hair follicle stem cells.

PLD is an effective and safer alternative for treating breast cancer.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Polyethylene alanine caused hair loss in young lab animals but not in adults, with hair regrowth occurring within 20 days.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.